Abercrombie, ED, Keefe, KA, DiFrischia, DS, Zigmond, MJ (1989). Differential effect of stress on in vivo dopamine release in striatum, nucleus accumbens, and medial frontal cortex. Journal of Neurochemistry 52, 1655–1658.
Arseneault, L, Cannon, M, Fisher, HL, Polanczyk, G, Moffitt, TE, Caspi, A (2011). Childhood trauma and children's emerging psychotic symptoms: a genetically sensitive longitudinal cohort study. American Journal of Psychiatry 168, 65–72.
Bijl, RV, Ravelli, A, van Zessen, G (1998 a). Prevalence of psychiatric disorder in the general population: results of The Netherlands Mental Health Survey and Incidence Study (NEMESIS). Social Psychiatry and Psychiatric Epidemiology 33, 587–595.
Bijl, RV, van Zessen, G, Ravelli, A, de Rijk, C, Langendoen, Y (1998 b). The Netherlands Mental Health Survey and Incidence Study (NEMESIS): objectives and design. Social Psychiatry and Psychiatric Epidemiology 33, 581–586.
Bossong, MG, van Berckel, BN, Boellaard, R, Zuurman, L, Schuit, RC, Windhorst, AD, van Gerven, JM, Ramsey, NF, Lammertsma, AA, Kahn, RS (2009). Delta 9-tetrahydrocannabinol induces dopamine release in the human striatum. Neuropsychopharmacology 34, 759–766.
Brenner, K, Schmitz, N, Pawliuk, N, Fathalli, F, Joober, R, Ciampi, A, King, S (2007). Validation of the English and French versions of the Community Assessment of Psychic Experiences (CAPE) with a Montreal community sample. Schizophrenia Research 95, 86–95.
Cadoni, C, Pisanu, A, Solinas, M, Acquas, E, Di Chiara, G (2001). Behavioural sensitization after repeated exposure to Delta 9-tetrahydrocannabinol and cross-sensitization with morphine. Psychopharmacology (Berlin) 158, 259–266.
Cadoni, C, Valentini, V, Di Chiara, G (2008). Behavioral sensitization to delta 9-tetrahydrocannabinol and cross-sensitization with morphine: differential changes in accumbal shell and core dopamine transmission. Journal of Neurochemistry 106, 1586–1593.
Cheer, JF, Wassum, KM, Heien, ML, Phillips, PE, Wightman, RM (2004). Cannabinoids enhance subsecond dopamine release in the nucleus accumbens of awake rats. Journal of Neuroscience 24, 4393–4400.
Clarke, MC, Tanskanen, A, Huttunen, M, Whittaker, JC, Cannon, M (2009). Evidence for an interaction between familial liability and prenatal exposure to infection in the causation of schizophrenia. American Journal of Psychiatry 166, 1025–1030.
Collip, D, Myin-Germeys, I, van Os, J (2008). Does the concept of ‘sensitization’ provide a plausible mechanism for the putative link between the environment and schizophrenia? Schizophrenia Bulletin 34, 220–225.
Corcoran, C, Malaspina, D (2001). Traumatic brain injury and schizophrenia. International Journal of Mental Health 30, 17–33.
Cougnard, A, Marcelis, M, Myin-Germeys, I, De Graaf, R, Vollebergh, W, Krabbendam, L, Lieb, R, Wittchen, HU, Henquet, C, Spauwen, J, van Os, J (2007). Does normal developmental expression of psychosis combine with environmental risk to cause persistence of psychosis? A psychosis proneness-persistence model. Psychological Medicine 37, 513–527.
Darroch, J (1997). Biologic synergism and parallelism. American Journal of Epidemiology 145, 661–668.
Davis, KL, Kahn, RS, Ko, G, Davidson, M (1991). Dopamine in schizophrenia: a review and reconceptualization. American Journal of Psychiatry 148, 1474–1486.
de Graaf, R, Bijl, RV, Smit, F, Ravelli, A, Vollebergh, WA (2000). Psychiatric and sociodemographic predictors of attrition in a longitudinal study: The Netherlands Mental Health Survey and Incidence Study (NEMESIS). American Journal of Epidemiology 152, 1039–1047.
Di Forti, M, Morgan, C, Dazzan, P, Pariante, C, Mondelli, V, Marques, TR, Handley, R, Luzi, S, Russo, M, Paparelli, A, Butt, A, Stilo, SA, Wiffen, B, Powell, J, Murray, RM (2009). High-potency cannabis and the risk of psychosis. British Journal of Psychiatry 195, 488–491.
Dill, DL, Chu, JA, Grob, MC, Eisen, SV (1991). The reliability of abuse history reports: a comparison of two inquiry formats. Comprehensive Psychiatry 32, 166–169.
Dominguez, MD, Wichers, M, Lieb, R, Wittchen, HU, van Os, J (2010). Evidence that onset of clinical psychosis is an outcome of progressively more persistent subclinical psychotic experiences: an 8-year cohort study. Schizophrenia Bulletin 37, 84–93.
D'Souza, DC, Abi-Saab, WM, Madonick, S, Forselius-Bielen, K, Doersch, A, Braley, G, Gueorguieva, R, Cooper, TB, Krystal, JH (2005). Delta-9-tetrahydrocannabinol effects in schizophrenia: implications for cognition, psychosis, and addiction. Biological Psychiatry 57, 594–608.
Elklit, A, Shevlin, M (2010). Female sexual victimization predicts psychosis: a case-control study based on the Danish Registry System. Schizophrenia Bulletin. Published online: 20 May 2010. doi:10.1093/schbul/sbq048.
Engert, V, Joober, R, Meaney, MJ, Hellhammer, DH, Pruessner, JC (2009). Behavioral response to methylphenidate challenge: influence of early life parental care. Developmental Psychobiology 51, 408–416.
Fergusson, DM, Lynskey, MT (1997). Physical punishment/maltreatment during childhood and adjustment in young adulthood. Child Abuse and Neglect 21, 617–630.
Fisher, HL, Jones, PB, Fearon, P, Craig, TK, Dazzan, P, Morgan, K, Hutchinson, G, Doody, GA, McGuffin, P, Leff, J, Murray, RM, Morgan, C (2010). The varying impact of type, timing and frequency of exposure to childhood adversity on its association with adult psychotic disorder. Psychological Medicine 40, 1967–1978.
Freeman, D, Fowler, D (2009). Routes to psychotic symptoms: trauma, anxiety and psychosis-like experiences. Psychiatry Research 169, 107–112.
French, ED, Dillon, K, Wu, X (1997). Cannabinoids excite dopamine neurons in the ventral tegmentum and substantia nigra. Neuroreport 8, 649–652.
Glenthoj, BY (1995). The brain dopaminergic system. Pharmacological, behavioural and electrophysiological studies. Danish Medical Bulletin 42, 1–21.
GROUP (2011). Evidence that familial liability for psychosis is expressed as differential sensitivity to cannabis: an analysis of patient-sibling and sibling-control pairs. Archives of General Psychiatry 68, 138–147.
Hanssen, M, Bak, M, Bijl, R, Vollebergh, W, van Os, J (2005). The incidence and outcome of subclinical psychotic experiences in the general population. British Journal of Clinical Psychology 44, 181–191.
Hanssen, M, Peeters, F, Krabbendam, L, Radstake, S, Verdoux, H, van Os, J (2003). How psychotic are individuals with non-psychotic disorders? Social Psychiatry and Psychiatric Epidemiology 38, 149–154.
Harley, M, Kelleher, I, Clarke, M, Lynch, F, Arseneault, L, Connor, D, Fitzpatrick, C, Cannon, M (2010). Cannabis use and childhood trauma interact additively to increase the risk of psychotic symptoms in adolescence. Psychological Medicine 40, 1627–1634.
Henquet, C, Krabbendam, L, de Graaf, R, ten Have, M, van Os, J (2006). Cannabis use and expression of mania in the general population. Journal of Affective Disorders 95, 103–110.
Henquet, C, Krabbendam, L, Spauwen, J, Kaplan, C, Lieb, R, Wittchen, HU, van Os, J (2005). Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people. British Medical Journal 330, 11.
Henquet, C, Di Forti, M, Morrison, P, Kuepper, R, Murray, RM (2008). Gene-environment interplay between cannabis and psychosis. Schizophrenia Bulletin 34, 1111–1121.
Henquet, C, van Os, J, Kueper, R, Delespaul, P, Smits, M, Campo, JA, Myin-Germeys, I (2010). Psychosis reactivity to cannabis use in daily life: an experience sampling study. British Journal Psychiatry 196, 447–453.
Houston, JE, Murphy, J, Adamson, G, Stringer, M, Shevlin, M (2008). Childhood sexual abuse, early cannabis use, and psychosis: testing an interaction model based on the National Comorbidity Survey. Schizophrenia Bulletin 34, 580–585.
Janssen, I, Krabbendam, L, Bak, M, Hanssen, M, Vollebergh, W, de Graaf, R, van Os, J (2004). Childhood abuse as a risk factor for psychotic experiences. Acta Psychiatrica Scandinavica 109, 38–45.
Kapur, S (2003). Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. American Journal of Psychiatry 160, 13–23.
Kelleher, I, Harley, M, Lynch, F, Arseneault, L, Fitzpatrick, C, Cannon, M (2008). Associations between childhood trauma, bullying and psychotic symptoms among a school-based adolescent sample. British Journal of Psychiatry 193, 378–382.
Kendler, KS, Karkowski-Shuman, L (1997). Stressful life events and genetic liability to major depression: genetic control of exposure to the environment? Psychological Medicine 27, 539–547.
Kendler, KS, Kessler, RC, Walters, EE, MacLean, C, Neale, MC, Heath, AC, Eaves, LJ (1995). Stressful life events, genetic liability, and onset of an episode of major depression in women. American Journal of Psychiatry 152, 833–842.
Kokkevi, A, Fotiou, A, Richardson, C (2007). Drug use in the general population of Greece over the last 20 years: results from nationwide household surveys. European Addiction Research 13, 167–176.
Kokkevi, A, Nic Gabhainn, S, Spyropoulou, M (2006). Early initiation of cannabis use: a cross-national European perspective. Journal of Adolescent Health 39, 712–719.
Konings, M, Bak, M, Hanssen, M, van Os, J, Krabbendam, L (2006). Validity and reliability of the CAPE: a self-report instrument for the measurement of psychotic experiences in the general population. Acta Psychiatrica Scandinavica 114, 55–61.
Konings, M, Maharajh, HD (2006). Cannabis use and mood disorders: patterns of clinical presentations among adolescents in a developing country. International Journal of Adolescent Medicine and Health 18, 221–233.
Kuepper, R, Morrison, PD, van Os, J, Murray, RM, Kenis, G, Henquet, C (2010). Does dopamine mediate the psychosis-inducing effects of cannabis? A review and integration of findings across disciplines. Schizophrenia Research 121, 107–117.
Laruelle, M (2000). The role of endogenous sensitization in the pathophysiology of schizophrenia: implications from recent brain imaging studies. Brain Research Reviews 31, 371–384.
Lataster, T, van Os, J, Drukker, M, Henquet, C, Feron, F, Gunther, N, Myin-Germeys, I (2006). Childhood victimisation and developmental expression of non-clinical delusional ideation and hallucinatory experiences: victimisation and non-clinical psychotic experiences. Social Psychiatry and Psychiatric Epidemiology 41, 423–428.
Mackie, CJ, Castellanos-Ryan, N, Conrod, PJ (2010). Developmental trajectories of psychotic-like experiences across adolescence: impact of victimization and substance use. Psychological Medicine 29, 1–12.
MacLean, KI, Littleton, JM (1977). Environmental stress as a factor in the response of rat brain catecholamine metabolism to delta8-tetrahydrocannabinol. European Journal of Pharmacology 41, 171–182.
MacMillan, HL, Boyle, MH, Wong, MY, Duku, EK, Fleming, JE, Walsh, CA (1999). Slapping and spanking in childhood and its association with lifetime prevalence of psychiatric disorders in a general population sample. Canadian Medical Association Journal 161, 805–809.
Marcelis, M, van Os, J, Sham, P, Jones, P, Gilvarry, C, Cannon, M, McKenzie, K, Murray, R (1998). Obstetric complications and familial morbid risk of psychiatric disorders. American Journal of Medical Genetics 81, 29–36.
Menti, E, Lekka, NP, Assimakopoulos, K, Varvarigou, A, Beratis, NG, Beratis, S (2007). Smoking, psychosocial factors, psychopathologic behavior, and other related conditions in hospitalized youth suicide attempters. Comprehensive Psychiatry 48, 522–528.
Mokler, DJ, Robinson, SE, Johnson, JH, Hong, JS, Rosecrans, JA (1987). Neonatal administration of delta-9-tetrahydrocannabinol (THC) alters the neurochemical response to stress in the adult Fischer-344 rat. Neurotoxicology and Teratology 9, 321–327.
Moore, TH, Zammit, S, Lingford-Hughes, A, Barnes, TR, Jones, PB, Burke, M, Lewis, G (2007). Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 370, 319–328.
Morgan, CJ, Schafer, G, Freeman, TP, Curran, HV (2010). Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study: naturalistic study [corrected]. British Journal of Psychiatry 197, 285–290.
Myin-Germeys, I, Delespaul, P, van Os, J (2005). Behavioural sensitization to daily life stress in psychosis. Psychological Medicine 35, 733–741.
Peters, ER, Day, S, Garety, PA (1996). The Peters et al. Delusions Inventory (PDI): new forms for the 21-item version. Schizophrenia Research 18, 118.
Polanczyk, G, Moffitt, TE, Arseneault, L, Cannon, M, Ambler, A, Keefe, RS, Houts, R, Odgers, CL, Caspi, A (2010). Etiological and clinical features of childhood psychotic symptoms: results from a birth cohort. Archives of General Psychiatry 67, 328–338.
Poulton, R, Caspi, A, Moffitt, TE, Cannon, M, Murray, R, Harrington, H (2000). Children's self-reported psychotic symptoms and adult schizophreniform disorder: a 15-year longitudinal study. Archives of General Psychiatry 57, 1053–1058.
Read, J, Bentall, RP, Fosse, R (2009). Time to abandon the bio-bio-bio model of psychosis: exploring the epigenetic and psychological mechanisms by which adverse life events lead to psychotic symptoms. Epidemiologia e Psichiatria Sociale 18, 299–310.
Read, J, Perry, BD, Moskowitz, A, Connolly, J (2001). The contribution of early traumatic events to schizophrenia in some patients: a traumagenic neurodevelopmental model. Psychiatry 64, 319–345.
Read, JP, Stern, AL, Wolfe, J, Ouimette, PC (1997). Use of a screening instrument in women's health care: detecting relationships among victimization history, psychological distress, and medical complaints. Women and Health 25, 1–17.
Rodrigues, AJ, Leao, P, Carvalho, M, Almeida, OF, Sousa, N (2011). Potential programming of dopaminergic circuits by early life stress. Psychopharmacology (Berlin) 214, 107–120.
Schreier, A, Wolke, D, Thomas, K, Horwood, J, Hollis, C, Gunnell, D, Lewis, G, Thompson, A, Zammit, S, Duffy, L, Salvi, G, Harrison, G (2009). Prospective study of peer victimization in childhood and psychotic symptoms in a nonclinical population at age 12 years. Archives of General Psychiatry 66, 527–536.
Scott, J, Chant, D, Andrews, G, Martin, G, McGrath, J (2007). Association between trauma exposure and delusional experiences in a large community-based sample. British Journal of Psychiatry 190, 339–343.
Semple, DM, McIntosh, AM, Lawrie, SM (2005). Cannabis as a risk factor for psychosis: systematic review. Journal of Psychopharmacology 19, 187–194.
Shevlin, M, Dorahy, MJ, Adamson, G (2007). Trauma and psychosis: an analysis of the National Comorbidity Survey. American Journal of Psychiatry 164, 166–169.
Shevlin, M, Houston, JE, Dorahy, MJ, Adamson, G (2008). Cumulative traumas and psychosis: an analysis of the National Comorbidity Survey and the British Psychiatric Morbidity Survey. Schizophrenia Bulletin 34, 193–199.
Shevlin, M, Murphy, J, Houston, JE, Adamson, G (2009). Childhood sexual abuse, early cannabis use, and psychosis: testing the effects of different temporal orderings based on the National Comorbidity Survey. Psychosis: Psychological, Social and Integrative Approaches 1, 19–28.
Smeets, R (1993). Composite International Diagnostic Interview (CIDI), version 1.1. World Health Organization: Geneva.
Soliman, A, O'Driscoll, GA, Pruessner, J, Holahan, AL, Boileau, I, Gagnon, D, Dagher, A (2008). Stress-induced dopamine release in humans at risk of psychosis: a [11C]raclopride PET study. Neuropsychopharmacology 33, 2033–2041.
Spauwen, J, Krabbendam, L, Lieb, R, Wittchen, HU, van Os, J (2006). Impact of psychological trauma on the development of psychotic symptoms: relationship with psychosis proneness. British Journal of Psychiatry 188, 527–533.
Stefanis, NC, Delespaul, P, Henquet, C, Bakoula, C, Stefanis, CN, van Os, J (2004). Early adolescent cannabis exposure and positive and negative dimensions of psychosis. Addiction 99, 1333–1341.
Stokes, PR, Egerton, A, Watson, B, Reid, A, Breen, G, Lingford-Hughes, A, Nutt, DJ, Mehta, MA (2010). Significant decreases in frontal and temporal [11C]-raclopride binding after THC challenge. NeuroImage 52, 1521–1527.
Stokes, PR, Mehta, MA, Curran, HV, Breen, G, Grasby, PM (2009). Can recreational doses of THC produce significant dopamine release in the human striatum? NeuroImage 48, 186–190.
Tanda, G, Pontieri, FE, Di Chiara, G (1997). Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism. Science 276, 2048–2050.
Tidey, JW, Miczek, KA (1996). Social defeat stress selectively alters mesocorticolimbic dopamine release: an in vivo microdialysis study. Brain Research 721, 140–149.
Tzoumaka-Bakoula, C (1987). The Greek National Perinatal Survey. I: Design, methodology, case ascertainment. Paediatric and Perinatal Epidemiology 1, 43–55.
van Os, J, Bak, M, Hanssen, M, Bijl, RV, de Graaf, R, Verdoux, H (2002). Cannabis use and psychosis: a longitudinal population-based study. American Journal of Epidemiology 156, 319–327.
van Os, J, Kapur, S (2009). Schizophrenia. Lancet 374, 635–645.
van Os, J, Pedersen, CB, Mortensen, PB (2004). Confirmation of synergy between urbanicity and familial liability in the causation of psychosis. American Journal of Psychiatry 161, 2312–2314.
van Os, J, Sham, P (2003). Gene-environment interactions. In The Epidemiology of Schizophrenia (ed. Murray, R. M., Jones, P. B., Susser, E., van Os and, J. Cannon, M.), pp. 235–254. Cambridge University Press: Cambridge.
Verdoux, H, Gindre, C, Sorbara, F, Tournier, M, Swendsen, JD (2003 a). Effects of cannabis and psychosis vulnerability in daily life: an experience sampling test study. Psychological Medicine 33, 23–32.
Verdoux, H, Sorbara, F, Gindre, C, Swendsen, JD, van Os, J (2003 b). Cannabis use and dimensions of psychosis in a nonclinical population of female subjects. Schizophrenia Research 59, 77–84.
Voruganti, LN, Slomka, P, Zabel, P, Mattar, A, Awad, AG (2001). Cannabis induced dopamine release: an in-vivo SPECT study. Psychiatry Research 107, 173–177.
Whitfield, CL, Dube, SR, Felitti, VJ, Anda, RF (2005). Adverse childhood experiences and hallucinations. Child Abuse and Neglect 29, 797–810.
Wicks, S, Hjern, A, Gunnell, D, Lewis, G, Dalman, C (2005). Social adversity in childhood and the risk of developing psychosis: a national cohort study. American Journal of Psychiatry 162, 1652–1657.
Wone, I, Dia, AT, Ndiaye, P, Fall, IS, Sarr, YF (2004). Prevalence of cannabis use among students in Dakar [in French]. Santé 14, 49–53.
Wurr, CJ, Partridge, IM (1996). The prevalence of a history of childhood sexual abuse in an acute adult inpatient population. Child Abuse and Neglect 20, 867–872.
Zammit, S, Spurlock, G, Williams, H, Norton, N, Williams, N, O'Donovan, MC, Owen, MJ (2007). Genotype effects of CHRNA7, CNR1 and COMT in schizophrenia: interactions with tobacco and cannabis use. British Journal of Psychiatry 191, 402–407.